N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial

N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism

(2015) Mohammadali Nikoo et al.   CLINICAL NEUROPHARMACOLOGY

Decreased thalamic glutamate level in unmedicated adult obsessive–compulsive disorder patients detected by proton magnetic resonance spectroscopy

(2015) Yajing Zhu et al.   JOURNAL OF AFFECTIVE DISORDERS

Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial

(2015) M. Shalbafan et al.   PHARMACOPSYCHIATRY

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

(2014) Mahnaz Heidari et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers

(2014) Michael Van Ameringen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia

(2013) Mehdi Farokhnia et al.   CLINICAL NEUROPHARMACOLOGY

Obsessive compulsive disorder and the glutamatergic system

(2013) Catherine Kariuki-Nyuthe et al.   CURRENT OPINION IN PSYCHIATRY

Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach

(2013) Marco A Grados et al.   Expert Opinion on Drug Discovery

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

(2013) Carolyn I Rodriguez et al.   NEUROPSYCHOPHARMACOLOGY

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

(2013) Mohammad Haghighi et al.   PSYCHOPHARMACOLOGY

The promise of N-acetylcysteine in neuropsychiatry

(2013) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

(2012) Michael H. Bloch et al.   BIOLOGICAL PSYCHIATRY

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder

(2012) Neda Askari et al.   CNS DRUGS

Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial

(2012) Arash Mowla et al.   CNS SPECTRUMS

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder

(2012) Hamid Afshar et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

(2012) Ali Ghaleiha et al.   JOURNAL OF PSYCHIATRIC RESEARCH

N-acetylcysteine augmentation in treatment resistant obsessive compulsive disorder: A case series

(2012) Michael Van Ameringen et al.   Journal of Obsessive-Compulsive and Related Disorders

Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment

(2011) Christopher Pittenger et al.   PHARMACOLOGY & THERAPEUTICS

Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Elias Aboujaoude et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

(2008) Christopher Pittenger et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report

(2008) Ö. Uzun   JOURNAL OF PSYCHOPHARMACOLOGY

Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive–compulsive disorder

(2008) Ercan Ozdemir et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Glutathione: a novel treatment target in psychiatry

(2008) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES